AQP4 and multiple sclerosis: Recent studies proposed that anti-MOG antibody-associated demyelinating diseases were indeed a clinical spectrum in pediatric patients and that their clinical features were different from those of multiple sclerosis and NMOSD with anti-aquaporin-4 (AQP4) antibody [1, 2].